MiMedx Group, Inc.MDXGNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+14.8%
5Y CAGR+13.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+14.8%/yr
vs +7.3%/yr prior
5Y CAGR
+13.2%/yr
Consistent
Acceleration
+7.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$73.01M+21.5%
2024$60.07M+10.0%
2023$54.63M+13.1%
2022$48.32M+21.9%
2021$39.63M+0.8%
2020$39.33M-8.7%
2019$43.08M+18.4%
2018$36.39M+3.3%
2017$35.22M+8.7%
2016$32.41M-